Redox-regulated mechanisms in asthma
Tomoaki Hoshino1, Masaki Okamoto, Satoko Takei
1Divisions of Respirology, Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. hoshino@med.kurume-u.ac.jp
Antioxidants & Redox Signaling
|January 9, 2008
Summary
Thioredoxin 1 (TRX1) protects lungs from oxidative stress. Exogenous TRX1 effectively reduces airway inflammation, hyperresponsiveness, and remodeling in asthma mouse models, suggesting clinical benefits.
Area of Science:
- Pulmonary Medicine
- Immunology
- Biochemistry
Background:
- Lung homeostasis relies on redox balance, with high antioxidant levels crucial for protection.
- Asthma involves increased airway inflammation and reactive oxygen/nitrogen species due to inflammatory cells like eosinophils.
- Human thioredoxin 1 (TRX1) is a redox-active protein with potent reducing capabilities essential for cellular protection.
Purpose of the Study:
- To investigate the role and clinical benefits of thioredoxin 1 (TRX1) in asthma.
- To evaluate the efficacy of exogenous TRX1 in mitigating asthma-related lung pathology in mouse models.
Main Methods:
- Utilized mouse models of asthma, including prolonged antigen exposure.
- Administered exogenous TRX1 to assess its impact on airway hyperresponsiveness, inflammation, and remodeling.
- Measured inflammatory cell counts, particularly eosinophils, and assessed airway remodeling markers.
Main Results:
- Exogenous TRX1 significantly inhibited airway hyperresponsiveness and pulmonary inflammation, including eosinophilia, in asthma models.
- Exogenous TRX1 was shown to improve established airway remodeling in a prolonged antigen-exposure asthma model.
- Both exogenous and endogenous TRX1 demonstrated a preventative effect on the development of airway remodeling.
Conclusions:
- TRX1 plays a critical protective role in the lungs against various injuries and inflammation.
- Exogenous TRX1 exhibits significant therapeutic potential for managing airway hyperresponsiveness, inflammation, and remodeling in asthma.
- TRX1 represents a promising therapeutic target for clinical intervention in asthma management.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...